Literature DB >> 8839168

Interleukin-12 in the pathogenesis and therapy of HIV disease.

J Chehimi1, C Paganin, I Frank, S Chouaib, S Starr, G Trinchieri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8839168     DOI： 10.1016/0923-2494(96)83038-0

Source DB:  PubMed          Journal:  Res Immunol        ISSN： 0923-2494


× No keyword cloud information.
  5 in total

Review 1.  Interleukin-12 in infectious diseases.

Authors:  L Romani; P Puccetti; F Bistoni
Journal:  Clin Microbiol Rev       Date:  1997-10       Impact factor: 26.132

2.  Interferon (IFN) consensus sequence-binding protein, a transcription factor of the IFN regulatory factor family, regulates immune responses in vivo through control of interleukin 12 expression.

Authors:  N A Giese; L Gabriele; T M Doherty; D M Klinman; L Tadesse-Heath; C Contursi; S L Epstein; H C Morse
Journal:  J Exp Med       Date:  1997-11-03       Impact factor: 14.307

3.  Interleukin-12p70 expression by dendritic cells of HIV-1-infected patients fails to stimulate gag-specific immune responses.

Authors:  Ellen Van Gulck; Nathalie Cools; Derek Atkinson; Lotte Bracke; Katleen Vereecken; Marc Vekemans; Viggo F I Van Tendeloo; Zwi N Berneman; Guido Vanham
Journal:  Clin Dev Immunol       Date:  2012-07-12

Review 4.  Optimizing dendritic cell-based immunotherapy: tackling the complexity of different arms of the immune system.

Authors:  Ilse Van Brussel; Zwi N Berneman; Nathalie Cools
Journal:  Mediators Inflamm       Date:  2012-07-18       Impact factor: 4.711

5.  Exposure of Human CD4 T Cells to IL-12 Results in Enhanced TCR-Induced Cytokine Production, Altered TCR Signaling, and Increased Oxidative Metabolism.

Authors:  Aldo Vacaflores; Nicole M Chapman; John T Harty; Martin J Richer; Jon C D Houtman
Journal:  PLoS One       Date:  2016-06-09       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.